New trends in conventional treatment of ADD/ADHD patients
Prof. Manfred Doepfner, PhD
Department for Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy,
Medical Faculty of the University of Cologne, Germany
Conventional treatment of children, adolescents and adults with ADHD comprises cognitive behavior therapy (including parent management training und school-based intervention in children and adolescents) and pharmacotherapy with psychostimulants or atomoxetine. Recent meta analyses of empirical research demonstrate quite consistently small to strong effects of both treatment approaches in well designed randomized controlled trials. Some of the new treatment approaches (e.g. omega-3/6 fatty acids, neurofeedback, neuropsychological trainings, telephone assisted self-help) show promising results. The lecture gives an overview over current status of empirical research and new evidenced based treatments.
Manfred Doepfner PhD is supervisor of behaviour therapy and director of the School for Child and Adolescent Cognitive Behavior Therapy at the University of Cologne and of the Institute for Clinical Child Psychology of the Christoph-Dornier-Foundation for Clinical Psychology at the University of Cologne. He received the German Psychology Prize for his scientific work in 2005. His main research interests are assessment, prevention, and treatment of ADHD, Conduct Disorders, Anxiety Disorders, Obsessive Compulsive Disorders and Tic Disorders. He is principal investigator of the Cologne Adaptive Multimodal Treatment Study (CAMT), of several multicentre studies on pharmacotherapy and psychotherapy of ADHD and conduct disorders, of prevention studies for externalizing problem behaviour in children, and on self-help-interventions for parents of children and adolescents with ADHD.